🕵️ Xeris Biopharma Holdings, Inc. ($XERS)
SEC insider & ownership activity, last 12 months · CIK 1867096 · every row links its SEC filing
Over the last 12 months insiders sold $4.8M with no open-market buying against it. Hecht Beth sold $1.3M through a 10b5-1 trading plan in 12 lots (Nov–Sep). 1 planned sale is pending, the largest $144K (Steven Pieper). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 9 sellers, $4.8M (29 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Hecht Beth | 0 | – | 12 | $1.3M | Sep 1, 2026 |
| McCulloch Kevin | 0 | – | 4 | $1.1M | Sep 1, 2026 |
| Johnson John | 0 | – | 2 | $1.1M | Jun 4, 2026 |
| Pieper Steven | 0 | – | 4 | $468K | Sep 1, 2026 |
| John Shannon | 0 | – | 2 | $350K | Jan 5, 2026 |
| Barbara-Jean Bormann-Kennedy | 0 | – | 2 | $204K | Jun 4, 2026 |
| Dawn Halkuff | 0 | – | 1 | $122K | Jun 4, 2026 |
| Persky Marla | 0 | – | 1 | $91K | Jun 3, 2026 |
| Brady James Aloysius | 0 | – | 1 | $60K | Mar 30, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Vanguard Capital Management | 5.0% | 13G | Jul 31, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Steven Pieper | $168K | Aug 12, 2026 | filing ↗ |
| Steven Pieper | $231K | Jul 7, 2026 | filing ↗ |
| Steven Pieper | $144K | Jul 6, 2026 | filing ↗ |
| Beth Hecht | $396K | Jul 1, 2026 | filing ↗ |
| Kevin McCulloch | $950K | Jul 1, 2026 | filing ↗ |
| Dawn Halkuff | $118K | Jun 4, 2026 | filing ↗ |
| John H. Johnson | $88K | Jun 4, 2026 | filing ↗ |
| Barbara-Jean Bormann-Kennedy | $94K | Jun 4, 2026 | filing ↗ |
| Marla Persky | $93K | Jun 3, 2026 | filing ↗ |
| James Brady | $59K | Mar 30, 2026 | filing ↗ |
| Beth Hecht | $408K | Mar 2, 2026 | filing ↗ |
| Kevin McCulloch | $433K | Jan 8, 2026 | filing ↗ |
| John H. Johnson | $977K | Dec 19, 2025 | filing ↗ |
| Barbara-Jean A. Bormann-Kennedy | $105K | Dec 12, 2025 | filing ↗ |
| John Shannon | $365K | Nov 13, 2025 | filing ↗ |
| Beth Hecht | $515K | Nov 11, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Sep 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 9, 2026 | filing ↗ |
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 15, 2026 | filing ↗ |
| Other events (8.01) | Jul 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 10, 2026 | filing ↗ |
| Other events (8.01) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 20, 2026 | filing ↗ |
| Earnings (2.02) | Mar 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Earnings (2.02) | Jan 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 1, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |